DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for ChemoCentryx, Inc. (CCXI)
« Back to company indexCCXI Chatter Timeline
Stock Ticker for CCXI
Most Active Tweeters for CCXI
| User | Tweets |
|---|---|
| @AmericanBanking | 5 |
| @bulletin_en | 4 |
| @TranscriptDaily | 3 |
| @SleekMoneycom | 2 |
| @stocknewstimes | 2 |
Recent Tweets for CCXI
 |
@AmericanBanking ChemoCentryx Inc $CCXI Receives Average Recommendation of “Buy” from Brokerages https://t.co/FOoxXZhG83 #stocks May 23rd 2019, 9:05am |
 |
@dailypoliticaln ChemoCentryx Inc $CCXI Given Average Rating of “Buy” by Analysts https://t.co/4c1vO1JEaG May 23rd 2019, 9:05am |
 |
@RVH_Investing @DeepSouthDoctor Be careful on $AUPH. $CCXI I liked at first, but I couldn’t handle the CEO May 23rd 2019, 7:05am |
 |
@dispatchtribune ChemoCentryx $CCXI Downgraded by ValuEngine to Buy https://t.co/bBTIRCccDG May 23rd 2019, 5:05am |
 |
@TheNoctrader $CCXI if you can look past the choppy price movement I see a descending wedge forming that will find a support abov… https://t.co/jLYTHFZs5R May 23rd 2019, 1:05am |
 |
@ThisLincolnian ChemoCentryx Inc $CCXI Expected to Announce Quarterly Sales of $10.08 Million https://t.co/VG0Hn202UD May 22nd 2019, 8:05am |
 |
@TranscriptDaily ChemoCentryx $CCXI Downgraded by ValuEngine https://t.co/ii0ht6n6IP May 22nd 2019, 2:05am |
 |
@WatchlistN ChemoCentryx $CCXI Stock Rating Lowered by ValuEngine https://t.co/ftdsmKrWmr May 21st 2019, 7:05am |
|
@TranscriptDaily ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/oc2XOPp8lQ May 21st 2019, 4:05am |
 |
@stocknewstimes ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/J7S183Zgny May 21st 2019, 4:05am |
 |
@SleekMoneycom ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/LDZE9cvIrd #investing May 21st 2019, 4:05am |
 |
@TheMarketsDaily ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/ZqALsDwA76 May 21st 2019, 4:05am |
|
@dailypoliticaln ChemoCentryx $CCXI Rating Lowered to Buy at ValuEngine https://t.co/UESmElJ3aI May 21st 2019, 12:05am |
 |
@SwingTradeIdeas $CCXI - ChemoCentryx (CCXI) Moves to Buy: Rationale Behind the Upgrade https://t.co/e9ahsRUxRv May 20th 2019, 10:05am |
 |
@1MinuteStock We calculated 63-day Expected Return of $CCXI for you: 17.68% https://t.co/UWhwbtw53i May 20th 2019, 7:05am |
 |
@Allstocknews $CCXI New Form EFFECT for ChemoCentryx, Inc. From our Stock News Alerts App May 20th 2019, 6:05am |
|
@TheMarketsDaily ChemoCentryx $CCXI Upgraded at Zacks Investment Research https://t.co/TRNFzpSzio May 19th 2019, 9:05am |
 |
@dakotafinancial ChemoCentryx $CCXI Upgraded at Zacks Investment Research https://t.co/xQzZybT8lA May 19th 2019, 9:05am |
 |
@OlympiaReport Analysts Anticipate ChemoCentryx Inc $CCXI Will Announce Quarterly Sales of $10.08 Million https://t.co/xiZh7Cr9Jc May 19th 2019, 5:05am |
|
@AmericanBanking Analysts Anticipate ChemoCentryx Inc $CCXI Will Post Quarterly Sales of $10.08 Million https://t.co/ZL5057T6fR #stocks May 19th 2019, 5:05am |
 |
@ZolmaxNews ChemoCentryx $CCXI Cut to Hold at Zacks Investment Research https://t.co/QMkHxlv7m3 May 19th 2019, 5:05am |
 |
@TickerReport B. Riley Brokers Boost Earnings Estimates for ChemoCentryx Inc $CCXI https://t.co/gpxVndFC4i May 19th 2019, 1:05am |
 |
@EnterpriseLeade ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/hyeqRrMTUH May 18th 2019, 12:05pm |
 |
@registrarjourn ChemoCentryx $CCXI Lowered to “Hold” at Zacks Investment Research https://t.co/SB1bIahNuc May 18th 2019, 12:05pm |
|
@stocknewstimes ChemoCentryx $CCXI Upgraded by Zacks Investment Research to Buy https://t.co/ffqctIaH8p May 18th 2019, 11:05am |
|
@SleekMoneycom ChemoCentryx $CCXI Upgraded by Zacks Investment Research to Buy https://t.co/5baahRRhlk #investing May 18th 2019, 11:05am |
 |
@bbnsnews B. Riley Weighs in on ChemoCentryx Inc’s FY2023 Earnings $CCXI https://t.co/Ort86bpe2E May 18th 2019, 5:05am |
 |
@WKRBNews Q2 2019 EPS Estimates for ChemoCentryx Inc Raised by B. Riley $CCXI https://t.co/4tGcwkKdB5 #markets May 18th 2019, 1:05am |
|
@dakotafinancial Zacks Investment Research Lowers ChemoCentryx $CCXI to Hold https://t.co/JP93nHCXwn May 17th 2019, 7:05pm |
|
@AmericanBanking Zacks: Analysts Expect ChemoCentryx Inc $CCXI to Announce -$0.21 Earnings Per Share https://t.co/VYAXc5mI6G #stocks May 17th 2019, 12:05pm |
|
@TranscriptDaily ChemoCentryx $CCXI Upgraded to Buy at Zacks Investment Research https://t.co/l1dxp85Xzv May 17th 2019, 8:05am |
|
@AmericanBanking B. Riley Comments on ChemoCentryx Inc’s Q2 2019 Earnings $CCXI https://t.co/wJzOxi27na #stocks May 17th 2019, 6:05am |
 |
@SwingTradeBot Rose Above 50 DMA today: $PFIN $CCXI ... https://t.co/qwiJH6vr1O May 16th 2019, 2:05pm |
 |
@ConsumerFeed ChemoCentryx $CCXI Upgraded by Zacks Investment Research to Buy https://t.co/oHnvh0kp3c May 16th 2019, 1:05pm |
|
@AmericanBanking FY2023 Earnings Estimate for ChemoCentryx Inc $CCXI Issued By B. Riley https://t.co/gecpyiGSQA #stocks May 16th 2019, 9:05am |
 |
@WeekHerald ChemoCentryx $CCXI Upgraded by Zacks Investment Research to Buy https://t.co/qsv0xP9nQv May 15th 2019, 8:05pm |
 |
@bulletin_en Baker Bros Advisors LP Has Lowered Stake in Chemocentryx $CCXI by $2.07 Million; Springbok Capital Management Has… https://t.co/DOb7iBlwxk May 14th 2019, 12:05pm |
 |
@happyycamperr @jsksrs $CCXI also conducting HS trials May 14th 2019, 5:05am |
|
@bulletin_en Contrasting of Jaguar Health Inc. $CCXI https://t.co/1TE4PQ2YY1 May 13th 2019, 6:05pm |
|
@bulletin_en CytRx Corporation $CCXI Contrasting side by side https://t.co/cU2pTkhuno May 13th 2019, 5:05pm |
 |
@DataTrials $CCXI Phase 3 A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis… Estimated… https://t.co/wbYT5X6QXF May 13th 2019, 4:05pm |
|
@DataTrials $CCXI Phase 2 A Study of CCX140-B in Subjects With FSGS… Estimated Primary Completion Date - 06/2019 May 13th 2019, 4:05pm |
|
@bbnsnews ChemoCentryx $CCXI Receives Buy Rating from HC Wainwright https://t.co/xvUiBah32O May 11th 2019, 9:05am |
|
@ZolmaxNews Piper Jaffray Companies Equities Analysts Increase Earnings Estimates for ChemoCentryx Inc $CCXI https://t.co/jj2X0HwzjC May 11th 2019, 3:05am |
|
@Allstocknews $CCXI New Form SC 13G/A for ChemoCentryx, Inc. From our Stock News Alerts App May 10th 2019, 1:05pm |
|
@bulletin_en Immuron Limited $CCXI Contrasting side by side https://t.co/rj0Ot8XONq May 10th 2019, 11:05am |
|
@WeekHerald Q2 2019 EPS Estimates for ChemoCentryx Inc $CCXI Lifted by Analyst https://t.co/ZC48XNkUN4 May 10th 2019, 2:05am |
 |
@NewsToDesk $CCXI $MOD: Hedge Funds Have Never Been More Bullish On ChemoCentryx Inc …: https://t.co/m6w6tCXCDi May 9th 2019, 11:05am |
|
@AmericanBanking Q2 2019 Earnings Estimate for ChemoCentryx Inc Issued By Piper Jaffray Companies $CCXI https://t.co/xWUOY8M7gL #stocks May 9th 2019, 8:05am |
|
@ThisLincolnian Q2 2019 Earnings Estimate for ChemoCentryx Inc Issued By Piper Jaffray Companies $CCXI https://t.co/cSRVotsSBk May 9th 2019, 8:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.